STVN
Stevanato Group·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
STVN Profile
Stevanato Group S.P.A.
The first worldwide producer of insulin cartridges for diabetes treatment
Life Science Tools and Services
--
07/16/2021
New York Stock Exchange
5,521
12-31
Common stock
Via Molinella 17, 35017 Piombino Dese – Padua, Italy
--
Stevanato Group S.p.A. is incorporated under the laws of the Republic of Italy. The company is a leading global provider of drug containment, drug delivery and diagnostic solutions and engineering solutions for the pharmaceutical, biotechnology and life science industries. The company offers an integrated, end-to-end portfolio of products, processes and services that meet customer needs throughout the drug lifecycle, from development to the clinical and commercial stages.
